
Data quality and integrity are of more importance now than atany other time in history. Insurers and providersare delving into advanced analytics, hopingto achieve more precise decisions for a range of applications.

Fuel population health analytics and manage risk adjustment with our award-winning suite of tools and data.


This model helps quantify the impact of care management programmes and redirecting care within the system on overall healthcare resource utilisation. Our tailored approach allows a range of different managed care programmes to be modelled.

Using our proprietary Health Cost Guidelines grouper, Milliman’s population cost model (PCM) helps you standardise measures of cost and utilisation across services and populations.

Milliman’s International Best Practice Benchmarks help quantify potentially avoidable admissions and beddays within a healthcare system to identify potential value opportunities.


This paper discusses the primary care redesign of seven US practices over the course of three years, including their reported utilisation and savings achievements.

The rapid uptake of genetic testing within the National Health Service (NHS) and current debate around genetics make evaluating tailored interventions increasingly more relevant to ensure an efficient use of NHS spend.

This article provides an introduction to the Milliman’s UK Health Cost Guidelines™ (HCGs), and insight into our findings, focusing primarily on the cancer-related research and future projections in cancer trends.
Using our proprietary Health Cost Guidelines grouper, Milliman’s population cost model (PCM) helps you standardise measures of cost and utilisation across services and populations.
Milliman’s International Best Practice Benchmarks help quantify potentially avoidable admissions and beddays within a healthcare system to identify potential value opportunities.